
AU-1235
CAS No. 1338780-86-1
AU-1235( AU1235 )
Catalog No. M11362 CAS No. 1338780-86-1
AU-1235 is a novel, specific mycobacterial membrane protein large 3 (MmpL3) inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 88 | Get Quote |
![]() ![]() |
5MG | 178 | Get Quote |
![]() ![]() |
10MG | 277 | Get Quote |
![]() ![]() |
25MG | 467 | Get Quote |
![]() ![]() |
50MG | 678 | Get Quote |
![]() ![]() |
100MG | 954 | Get Quote |
![]() ![]() |
500MG | 1908 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAU-1235
-
NoteResearch use only, not for human use.
-
Brief DescriptionAU-1235 is a novel, specific mycobacterial membrane protein large 3 (MmpL3) inhibitor.
-
DescriptionAU-1235 is a novel, specific mycobacterial membrane protein large 3 (MmpL3) inhibitor with MIC of 0.1 ug/mL (0.3 uM) against Mtb H37Rv.
-
In VitroAU1235 is similarly active against MDR isolates of M. tb displaying resistance to isoniazid, rifampicin, and pyrazinamide in addition to streptomycin, fluoroquinolones and/or ethambutol. AU1235 also inhibits Mycobacterium smegmatis and Mycobacterium fortuitum although the MICs (3.2 to 6.4 μg/ml) are significantly higher than against M. tb and M. bovis BCG.
-
In Vivo——
-
SynonymsAU1235
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1338780-86-1
-
Formula Weight324.347
-
Molecular FormulaC17H19F3N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 6 mg/mL 18.50 mM
-
SMILESC1C2CC3CC1CC(C2)(C3)NC(=O)NC4=C(C(=C(C=C4)F)F)F
-
Chemical NameN-Tricyclo[3.3.1.13,7]dec-1-yl-N'-(2,3,4-trifluorophenyl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Grzegorzewicz AE, et al. Nat Chem Biol. 2012 Feb 19;8(4):334-41.
2. Stanley SA, et al. ACS Chem Biol. 2012 Aug 17;7(8):1377-84.
molnova catalog



related products
-
MAC13243 HCl
MAC13243 HCl, an inhibitor of LolA, a periplasmic chaperone that transports lipoproteins from the inner membrane to the outer membrane, is an antimicrobial agent with specificity and significant inhibitory effects on Gram-negative bacteria.
-
Durlobactam
Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
-
Inh2-B1
Inh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM.